Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

Cited In for PubMed (Select 16728488)

1.

Development and validation of a melanoma risk score based on pooled data from 16 case-control studies.

Davies JR, Chang YM, Bishop DT, Armstrong BK, Bataille V, Bergman W, Berwick M, Bracci PM, Elwood JM, Ernstoff MS, Green A, Gruis NA, Holly EA, Ingvar C, Kanetsky PA, Karagas MR, Lee TK, Le Marchand L, Mackie RM, Olsson H, Ă˜sterlind A, Rebbeck TR, Reich K, Sasieni P, Siskind V, Swerdlow AJ, Titus L, Zens MS, Ziegler A, Gallagher RP, Barrett JH, Newton-Bishop J.

Cancer Epidemiol Biomarkers Prev. 2015 May;24(5):817-24. doi: 10.1158/1055-9965.EPI-14-1062. Epub 2015 Feb 24.

PMID:
25713022
2.

Melanoma characteristics in Brazil: demographics, treatment, and survival analysis.

Vazquez Vde L, Silva TB, Vieira Mde A, de Oliveira AT, Lisboa MV, de Andrade DA, Fregnani JH, Carneseca EC.

BMC Res Notes. 2015 Jan 16;8:4. doi: 10.1186/s13104-015-0972-8.

3.

A risk prediction model for smoking experimentation in Mexican American youth.

Talluri R, Wilkinson AV, Spitz MR, Shete S.

Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):2165-74. doi: 10.1158/1055-9965.EPI-14-0467. Epub 2014 Jul 25.

PMID:
25063521
4.

Development of a melanoma risk prediction model incorporating MC1R genotype and indoor tanning exposure: impact of mole phenotype on model performance.

Penn LA, Qian M, Zhang E, Ng E, Shao Y, Berwick M, Lazovich D, Polsky D.

PLoS One. 2014 Jul 8;9(7):e101507. doi: 10.1371/journal.pone.0101507. eCollection 2014.

5.

Individual risk of cutaneous melanoma in New Zealand: developing a clinical prediction aid.

Sneyd MJ, Cameron C, Cox B.

BMC Cancer. 2014 May 22;14:359. doi: 10.1186/1471-2407-14-359.

6.

Joint effect of multiple common SNPs predicts melanoma susceptibility.

Fang S, Han J, Zhang M, Wang LE, Wei Q, Amos CI, Lee JE.

PLoS One. 2013 Dec 31;8(12):e85642. doi: 10.1371/journal.pone.0085642. eCollection 2013.

7.

Perceived risk following melanoma genetic testing: a 2-year prospective study distinguishing subjective estimates from recall.

Aspinwall LG, Taber JM, Kohlmann W, Leaf SL, Leachman SA.

J Genet Couns. 2014 Jun;23(3):421-37. doi: 10.1007/s10897-013-9676-1. Epub 2013 Dec 10.

8.

MC1R genotype as a predictor of early-onset melanoma, compared with self-reported and physician-measured traditional risk factors: an Australian case-control-family study.

Cust AE, Goumas C, Vuong K, Davies JR, Barrett JH, Holland EA, Schmid H, Agha-Hamilton C, Armstrong BK, Kefford RF, Aitken JF, Giles GG, Bishop D, Newton-Bishop JA, Hopper JL, Mann GJ, Jenkins MA.

BMC Cancer. 2013 Sep 4;13:406. doi: 10.1186/1471-2407-13-406.

9.

User-centered development of a smart phone mobile application delivering personalized real-time advice on sun protection.

Buller DB, Berwick M, Shane J, Kane I, Lantz K, Buller MK.

Transl Behav Med. 2013 Sep;3(3):326-34. doi: 10.1007/s13142-013-0208-1.

10.

Randomized trial of tailored skin cancer prevention for children: the Project SCAPE family study.

Glanz K, Steffen AD, Schoenfeld E, Tappe KA.

J Health Commun. 2013;18(11):1368-83. doi: 10.1080/10810730.2013.778361. Epub 2013 Jun 27.

11.

A melanoma risk score in a Brazilian population.

Bakos L, Mastroeni S, Bonamigo RR, Melchi F, Pasquini P, Fortes C.

An Bras Dermatol. 2013 Mar-Apr;88(2):226-32. doi: 10.1590/S0365-05962013000200007. Erratum in: An Bras Dermatol. 2013 May-Jun;88(3):486. Mastroeni, Simeona [corrected to Mastroeni, Simona].

12.

Incidence of childhood and adolescent melanoma in the United States: 1973-2009.

Wong JR, Harris JK, Rodriguez-Galindo C, Johnson KJ.

Pediatrics. 2013 May;131(5):846-54. doi: 10.1542/peds.2012-2520. Epub 2013 Apr 15.

13.

A clinical risk prediction model for Barrett esophagus.

Thrift AP, Kendall BJ, Pandeya N, Vaughan TL, Whiteman DC; Study of Digestive Health.

Cancer Prev Res (Phila). 2012 Sep;5(9):1115-23. Epub 2012 Jul 11.

14.

Identifying Persons at Highest Risk of Melanoma Using Self-Assessed Risk Factors.

Williams LH, Shors AR, Barlow WE, Solomon C, White E.

J Clin Exp Dermatol Res. 2011;2(6). pii: 1000129.

15.

The contribution of health services research to improved dermatologic care.

Chren MM.

J Invest Dermatol. 2012 Mar;132(3 Pt 2):1003-7. doi: 10.1038/jid.2011.357. Epub 2011 Nov 10. Review.

16.

Regulatory approval of cancer risk-reducing (chemopreventive) drugs: moving what we have learned into the clinic.

Meyskens FL Jr, Curt GA, Brenner DE, Gordon G, Herberman RB, Finn O, Kelloff GJ, Khleif SN, Sigman CC, Szabo E; C-Change Chemoprevention Clinical Trials and Biomarkers Subcommittee.

Cancer Prev Res (Phila). 2011 Mar;4(3):311-23. doi: 10.1158/1940-6207.CAPR-09-0014.

17.

Sunbeds and sunlamps: who used them and their risk for melanoma.

Fears TR, Sagebiel RW, Halpern A, Elder DE, Holly EA, Guerry D 4th, Tucker MA.

Pigment Cell Melanoma Res. 2011 Jun;24(3):574-81. doi: 10.1111/j.1755-148X.2011.00842.x. Epub 2011 Mar 29.

18.

Comparison of discriminatory power and accuracy of three lung cancer risk models.

D'Amelio AM Jr, Cassidy A, Asomaning K, Raji OY, Duffy SW, Field JK, Spitz MR, Christiani D, Etzel CJ.

Br J Cancer. 2010 Jul 27;103(3):423-9. doi: 10.1038/sj.bjc.6605759. Epub 2010 Jun 29.

19.

Does MC1R genotype convey information about melanoma risk beyond risk phenotypes?

Kanetsky PA, Panossian S, Elder DE, Guerry D, Ming ME, Schuchter L, Rebbeck TR.

Cancer. 2010 May 15;116(10):2416-28. doi: 10.1002/cncr.24994.

20.

Cancer risk assessment for the primary care physician.

Korde LA, Gadalla SM.

Prim Care. 2009 Sep;36(3):471-88. doi: 10.1016/j.pop.2009.04.006.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk